Подписаться
Litviakov Nikolai V.
Litviakov Nikolai V.
Doctor Science, Head Laboratory of oncovirology of Cancer Research Institute of Tomsk NRMC
Подтвержден адрес электронной почты в домене oncology.tomsk.ru
Название
Процитировано
Процитировано
Год
Intratumor heterogeneity: nature and biological significance
TS Gerashchenko, EV Denisov, NV Litviakov, MV Zavyalova, ...
Biochemistry (Moscow) 78 (11), 1201-1215, 2013
163*2013
Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response
NV Litviakov, NV Cherdyntseva, MM Tsyganov, EV Denisov, EY Garbukov, ...
Cancer Chemotherapy and Pharmacology 71 (1), 153-163, 2013
862013
The presence of alveolar structures in invasive ductal NOS breast carcinoma is associated with lymph node metastasis
MV Zavyalova, VM Perelmuter, SV Vtorushin, EV Denisov, NV Litviakov, ...
Diagnostic Cytopathology, doi: 10.1002/dc.21852, 2011
692011
Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant …
T Liu, I Larionova, N Litviakov, V Riabov, M Zavyalova, M Tsyganov, ...
Oncoimmunology 7 (6), e1436922, 2018
682018
Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression
EV Denisov, NV Litviakov, MV Zavyalova, VM Perelmuter, SV Vtorushin, ...
Scientific reports 4 (1), 4709, 2014
682014
Natural and chemotherapy-induced clonal evolution of tumors
MK Ibragimova, MM Tsyganov, NV Litviakov
Biochemistry (Moscow) 82, 413-425, 2017
67*2017
Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy
NV Litviakov, NV Cherdyntseva, MM Tsyganov, EM Slonimskaya, ...
Oncotarget 7 (7), 7829, 2016
612016
The phenomenon of multi-drug resistance in the treatment of malignant tumors
SV Vtorushin, KY Khristenko, MV Zavyalova, VM Perelmuter, NV Litviakov, ...
Experimental oncology, 2014
572014
Мутации гена ТР53 при раке молочной железы и их взаимосвязь с клинико-патологическими параметрами заболевания
ЕВ Денисов, ЕА Малиновская, ЕЮ Гарбуков, НН Бабышкина, ...
Сибирский онкологический журнал, 39-40, 2008
55*2008
Influence of changing pulse repetition frequency on chemical and biological effects induced by low-intensity ultrasound in vitro
MA Buldakov, MA Hassan, QL Zhao, LB Feril Jr, N Kudo, T Kondo, ...
Ultrasonics sonochemistry 16 (3), 392-397, 2009
542009
Intratumoral morphological heterogeneity of breast cancer as an indicator of the metastatic potential and tumor chemosensitivity
TS Gerashchenko, MV Zavyalova, EV Denisov, NV Krakhmal, ...
Acta Naturae (англоязычная версия) 9 (1 (32)), 56-67, 2017
52*2017
Cell‐surface‐bound circulating DNA as a prognostic factor in lung cancer
SN Tamkovich, NV Litviakov, OE Bryzgunova, AY Dobrodeev, EY Rykova, ...
Annals of the New York Academy of Sciences 1137 (1), 214-217, 2008
492008
Phenotypic Drift as a Cause for Intratumoral Morphological Heterogeneity of Invasive Ductal Breast Carcinoma Not Otherwise Specified
MV Zavyalova, EV Denisov, LA Tashireva, TS Gerashchenko, ...
BioResearch Open Access, 2013
482013
Role of the immune component of tumor microenvironment in the efficiency of cancer treatment: perspectives for the personalized therapy
M Stakheyeva, V Riabov, I Mitrofanova, N Litviakov, E Choynzonov, ...
Current pharmaceutical design 23 (32), 4807-4826, 2017
452017
NF-kB as a potential prognostic marker and a candidate for targeted therapy of cancer
KA Gaptulbarova, MM Tsyganov, AM Pevzner, MK Ibragimova, ...
Experimental oncology 42 (4), 263-269, 2020
442020
Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy
N Litviakov, M Tsyganov, I Larionova, M Ibragimova, I Deryusheva, ...
Cancer chemotherapy and pharmacology 82, 99-109, 2018
402018
Разработка магнитоуправляемой системы для доставки химиопрепаратов на основе наноразмерных частиц железа
АИ Галанов, ТА Юрмазова, ГГ Савельев, МА Булдаков, ЮВ Рудык, ...
Сибирский онкологический журнал, 50-57, 2008
402008
Age-related function of tumor suppressor gene TP53: contribution to cancer risk and progression
NV Cherdyntseva, PA Gervas, NV Litviakov, MN Stakcheeva, ...
Experimental Oncology 32 (3), 205-208, 2010
392010
Human papillomavirus and colorectal cancer
MK Ibragimova, MM Tsyganov, NV Litviakov
Medical Oncology 35 (11), 140, 2018
382018
Genome-wide methylotyping resolves breast cancer epigenetic heterogeneity and suggests novel therapeutic perspectives
AS Tanas, VO Sigin, AI Kalinkin, NV Litviakov, EM Slonimskaya, ...
Epigenomics 11 (6), 605-617, 2019
372019
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20